This bacterial clearance exposes microbial epitopes homologous to tumor antigens, enabling their presentation via MHC-I and subsequent recognition by CD8+ T cells, which in turn establishes long-lasting antitumor immune memory capable of targeting both infected and uninfected cancer cells. The gene discussed is CD8A; the disease is neoplasm.